Search PubMed⌕ Search

PubMed · 15159281

Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: involvement of nitric oxide.

Abstract

1. The effects of short-term oral administration of red wine polyphenolic compounds (RWPC, 20 mg x kg(-1) day(-1) for 7 days) on haemodynamics, ex vivo cardiac responsiveness and ischaemia-reperfusion injury were investigated in rats. The involvement of nitric oxide (NO) was evaluated using the NO synthase inhibitor, N(G)-nitro-l-arginine methyl ester (l-NAME, 2 mg x kg(-1) day(-1) for 7 days), at a dose which did not affect blood pressure. 2. Ex vivo reactivity of hearts from RWPC-treated rats showed lower basal developed pressure, greater heart rate and decreased inotropic responses to either beta-adrenoceptor or muscarinic receptor stimulation with isoprenaline or carbachol, respectively.3. RWPC treatment did not modify cardiac expression of endothelial NO synthase or Cu/Zn superoxide dismutase. However, it increased nitrite in the coronary effluent. 4. In ischaemia-reperfusion, RWPC treatment reduced infarct size and oxidative stress, as shown by the myocardial content of the end products of lipid peroxidation, malondialdehyde and 4-hydroxynonenal, without affecting post-ischaemic contractile dysfunction. All the observed effects of RWPC were prevented by l-NAME treatment. 5. Altogether, these data show that short-term treatment with RWPC decreases blood pressure and cardiac responsiveness, and protects against post-ischaemic infarction via decreased oxidative stress. All the above effects of RWPC are sensitive to NO synthase inhibition that implies an involvement of NO-dependent pathway. This study suggests a basis for the beneficial effects of plant-derived polyphenols against cardiovascular disease.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hantamalala Ralay Ranaivo, Myriam Diebolt, Ramaroson Andriantsitohaina. 2004-05-24. Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: involvement of nitric oxide.. https://doi.org/10.1038/sj.bjp.0705833

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Resting pulse rates in a glaucoma clinic: the effect of topical and systemic beta-blocker usage.

INTRODUCTION: Beta-blockers have, for 25 years, been a commonly used agent in the treatment of raised intraocular pressure (IOP). Beta-blockers can also reduce the pulse rate. With no available literature examining a cohort of patients, this study aims to investigate the resting pulse rates in patients attending a specialist glaucoma clinic in order to identify if routine review of ophthalmic medication use is indicated. METHOD: The resting pulse rates of patients attending a glaucoma clinic were measured using pulseoximetry, with a medical and drug history established for each patient. RESULTS: In all, 205 patients were included in the study. A total of 101 (49%) of patients were using beta-blockers in some form. The mean pulse rate for patients not using beta-blockers (104 patients) was 76 beats per minute (bpm), for topical use only (68 patients) it was 70.3 bpm, for oral use (18 patients) it was 64.7 bpm, and 58 bpm for patients using both topical and oral beta-blockers (15 patients). Groups using beta-blockers (oral, topical, oral and topical) were considered in relation to patients not using beta-blockers. All groups using beta-blockers showed a significant association with causing a bradycardia of less than 60 bpm. Patients with a pulse rate of less than 50 bpm were significantly more likely to be using topical and oral beta-blockers than oral beta-blockers alone (P=0.01). CONCLUSION: Topical beta-blockers should be used with caution, even in the presence of established systemic beta-blocker use. Routine pulse rate monitoring and review of ophthalmic medication are indicated in patients using beta-blocker therapy.

Administration, Oral↗

Effects of alcohol and performance incentives on immediate working memory.

RATIONALE AND OBJECTIVES: The Sternberg Memory Scanning task was used to test the hypotheses that immediate working memory (WM) would be impaired during moderate rising blood alcohol concentrations (BACs), and provision of a rewarding incentive for good performance under alcohol would counteract this impairment. METHODS: Two groups (n=18) of social drinkers received either 0.62 g/kg alcohol (A) or a placebo (P). Reward (verbal feedback and money) for good performance was provided to another pair of alcohol and placebo groups (n=18) (AR and PR). All participants completed two tests when BACs in the alcohol groups were rising (68 and 80 mg/100 ml) and two tests during declining BACs (73 and 64 mg/100 ml). RESULTS: Comparisons of A and P groups showed that rising BACs impaired immediate WM [increased errors, slowed rate of mental scanning, slowed reaction time (RT) when a larger number of items had to be held in WM]. Comparisons of AR and PR groups showed that reward for good performance during rising BACs counteracted impairment in scanning rate and RT but did not reduce errors. Tests during declining BACs of 73 mg/100 ml indicated some symptoms of impairment abated before others. When BAC declined to 64 mg/106 ml, the groups no longer differed on any measure of WM. CONCLUSIONS: An acute dose of alcohol can impair aspects of immediate WM performance while BACs are rising, and some of these effects can be reversed when incentives to perform well are provided.

Administration, Oral↗

Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement.

RATIONALE: It is widely accepted that sleep facilitates memory consolidation. Hypnotics (e.g., benzodiazepines), which reportedly increase sleep efficiency but also modify sleep architecture, could affect memory improvement that occurs during sleep. OBJECTIVES: The present study examined the effects of single doses of two short half-life hypnotics, zolpidem and triazolam, on sleep-induced improvement of memory. METHODS: Twenty-two healthy volunteers participated in this randomized, double-blind, crossover study. All subjects received a single oral dose of zolpidem (10 mg), triazolam (0.25 mg) or placebo at 9 P.M.: and slept for 7.5+/-0.2 h. The effect of sleep on memory was investigated by comparing the performance of this group of volunteers with a group of 21 subjects in wakefulness condition. Declarative memory was evaluated by using a free-recall test of ten standard word and seven nonword lists. Subjects memorized the word and nonword lists 1 h before dosing and they were asked to recall the memorized lists 10 h after dosing. Digit symbol substitution test (DSST) and forward and backward digit tests were also given 1 h before and 10 h after dosing. RESULTS: Subjects who slept remembered more nonwords than those in wakefulness condition, but they did not recall significantly more standard words. Neither zolpidem nor triazolam affected the enhanced nonword recall observed after sleep. Finally, none of the hypnotics affected the improvement in the DSST performance of subjects who slept. CONCLUSIONS: The hypnotics tested did not interfere with the nocturnal sleep-induced improvement of memory.

Administration, Oral↗